Cart
sales@molnova.com
Transketolase-IN-4
CAS No. 419547-73-2
Transketolase-IN-4( —— )
Catalog No. M36468 CAS No. 419547-73-2
Transketolase-IN-4 is a transketolase inhibitor with an IC50 value of 3.9 μM.Transketolase-IN-4 inhibited Mycobacterium tuberculosis DXS with an IC50 value of 114.1 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 49 | Get Quote |
|
| 5MG | 69 | Get Quote |
|
| 10MG | 112 | Get Quote |
|
| 25MG | 228 | Get Quote |
|
| 50MG | 364 | Get Quote |
|
| 100MG | 583 | Get Quote |
|
| 500MG | 1215 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTransketolase-IN-4
-
NoteResearch use only, not for human use.
-
Brief DescriptionTransketolase-IN-4 is a transketolase inhibitor with an IC50 value of 3.9 μM.Transketolase-IN-4 inhibited Mycobacterium tuberculosis DXS with an IC50 value of 114.1 μM.
-
DescriptionTransketolase-IN-4 is a potent transketolase inhibitor (IC50=3.9 μM). Transketolase-IN-4 inhibits tumor cell proliferation of SW620, LS174T, and MIA PaCa-2. Transketolase-IN-4 is a possible Mycobacterium tuberculosis DXS inhibitor, with an IC50 value of 114.1 μM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorTransketolase | Antibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number419547-73-2
-
Formula Weight335.79
-
Molecular FormulaC19H14ClN3O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (372.26 mM; Ultrasonic )
-
SMILESO=C1N2C(=C(C=N2)C3=CC=C(Cl)C=C3)NC(CC4=CC=CC=C4)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Du MX, et al. Identification of novel small-molecule inhibitors for human transketolase by high-throughput screening with fluorescent intensity (FLINT) assay. J Biomol Screen. 2004 Aug;9(5):427-33.?
molnova catalog
related products
-
Endonuclease Antigen...
Endonuclease Antigenic Site
-
Tranilast
A compound that exhibits anti-inflammatory and immunomodulatory effects by inhibiting lipid mediator and cytokine release from inflammatory cells and interfering with PDGF- and TGF-β1-induced proliferation and migration of vascular medial smooth muscle cells.
-
AdTx1
Selective, high affinity, non-competitive α1A adrenoceptor antagonist (Ki = 0.35 nM). Exhibits no significant activity against a range of other GPCRs, including α2A, β1 and β2 adrenoceptors. Antagonizes effects of phenylephrine on isolated rabbit prostate muscle in vitro and on intra-urethral pressure in rats.
